COPD Maintenance Therapy with Tiotropium/Olodaterol Compared with Tiotropium: An Analysis in the Absence of Additional ICS Therapy

References

• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 report) 2019 [cited 2020 June 15]. Available from: https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.0wms.pdf
   Google Scholar
• Nici L , Mammen MJ , Charbek E , et al . Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(9):e56–e69. DOI:10.1164/rccm.202003-0625ST
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence . Chronic obstructive pulmonary disease in over 16s: diagnosis and management 2019 [cited 2020 June 15]. Available from: https://www.nice.org.uk/guidance/ng115/chapter/Recommendations#ftn.footnote_3
   Google Scholar
• Buhl R , Maltais F , Abrahams R , et al. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4). Eur Respir J. 2015;45(4):969–979. DOI:10.1183/09031936.00136014
   PubMed Web of Science ®Google Scholar
• Mahler DA , Decramer M , D'Urzo A , et al. Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study. Eur Respir J. 2014;43(6):1599–1609. DOI:10.1183/09031936.00124013
   PubMed Web of Science ®Google Scholar
• Malerba M , Foci V , Patrucco F , et al. Single inhaler LABA/LAMA for COPD. Front Pharmacol. 2019;10:390. DOI:10.3389/fphar.2019.00390
   PubMed Web of Science ®Google Scholar
• Vincken W , Aumann J , Chen H , et al. Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study. Int J Chron Obstruct Pulmon Dis. 2014;9:215–228. DOI:10.2147/COPD.S51592
   PubMed Web of Science ®Google Scholar
• Calverley PMA , Anzueto AR , Dusser D , et al. Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:1297–1308. DOI:10.2147/COPD.S153631
   PubMed Web of Science ®Google Scholar
• Singh D , Ferguson GT , Bolitschek J , et al. Tiotropium + olodaterol shows clinically meaningful improvements in quality of life. Respir Med. 2015;109(10):1312–1319. DOI:10.1016/j.rmed.2015.08.002
   PubMed Web of Science ®Google Scholar
• Witek TJ, Jr. , Mahler DA . Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J. 2003;21(2):267–272. DOI:10.1183/09031936.03.00068503a
   PubMed Web of Science ®Google Scholar
• Wedzicha JA , Decramer M , Ficker JH , et al. Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study. Lancet Respir Med. 2013;1(3):199–209. DOI:10.1016/S2213-2600(13)70052-3
   PubMed Web of Science ®Google Scholar
• Jones PW , Beeh KM , Chapman KR , et al. Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med. 2014;189(3):250–255. DOI:10.1164/rccm.201310-1863PP
   PubMed Web of Science ®Google Scholar
• Maltais F , Bjermer L , Kerwin EM , et al. Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial. Respir Res. 2019;20(1):238. DOI:10.1186/s12931-019-1193-9
   PubMed Web of Science ®Google Scholar
• Donohue JF , Jones PW , Bartels C , et al. Correlations between FEV1 and patient-reported outcomes: a pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2018;49:11–19. DOI:10.1016/j.pupt.2017.12.005
   PubMed Web of Science ®Google Scholar
• Bateman ED , Ferguson GT , Barnes N , et al. Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study. Eur Respir J. 2013;42(6):1484–1494. DOI:10.1183/09031936.00200212
   PubMed Web of Science ®Google Scholar
• Buhl R , Singh D , de la Hoz A , et al. Benefits of tiotropium/olodaterol compared with tiotropium in patients with COPD receiving only LAMA at baseline: pooled analysis of the TONADO® and OTEMTO® studies. Adv Ther. 2020;37(8):3485–3499. https://link.springer.com/article/10.1007%2Fs12325-020-01373-3
   PubMed Web of Science ®Google Scholar
• Buhl R , de la Hoz A , Xue W , et al. Efficacy of tiotropium/olodaterol compared with tiotropium as a first-line maintenance treatment in patients with COPD who are naïve to LAMA, LABA and ICS: pooled analysis of four clinical trials. Adv Ther. 2020;Epub ahead of print. DOI:10.1007/s12325-020-01411-0
   Web of Science ®Google Scholar
• Halpin DMG , de Jong HJI , Carter V , et al. Distribution, temporal stability and appropriateness of therapy of patients with COPD in the UK in relation to GOLD 2019. EClinicalMedicine. 2019;14:32–41. DOI:10.1016/j.eclinm.2019.07.003
   PubMedGoogle Scholar
• Vogelmeier CF , Román-Rodríguez M , Singh D , et al. Goals of COPD treatment: focus on symptoms and exacerbations. Respir Med. 2020;166:105938. DOI:10.1016/j.rmed.2020.105938
   PubMed Web of Science ®Google Scholar
• Izquierdo JL , Miravitlles M , Esquinas C , et al. Characteristics of COPD patients managed in respiratory medicine departments in Spain, according to GOLD groups and GesEPOC clinical phenotypes. Arch Bronconeumol. 2018;54(11):559–567. DOI:10.1016/j.arbres.2018.03.021
   PubMed Web of Science ®Google Scholar
• Vogelmeier C , Worth H , Buhl R , et al . “Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD. Int J Chron Obstruct Pulmon Dis. 2017;12:487–494. DOI:10.2147/COPD.S125616
   PubMed Web of Science ®Google Scholar
• Koblizek V , Milenkovic B , Barczyk A , et al. Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study. Eur Respir J. 2017;49(5):1601446. DOI:10.1183/13993003.01446-2016
   PubMed Web of Science ®Google Scholar